Legacy Investment Solutions, LLC Catalyst Pharmaceuticals, Inc. Transaction History
Legacy Investment Solutions, LLC
- $139 Million
- Q4 2024
A detailed history of Legacy Investment Solutions, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Legacy Investment Solutions, LLC holds 35 shares of CPRX stock, worth $743. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35
Previous 18
94.44%
Holding current value
$743
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CPRX
# of Institutions
345Shares Held
98.4MCall Options Held
13.4KPut Options Held
11.7K-
Black Rock Inc. New York, NY18.7MShares$397 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$179 Million0.0% of portfolio
-
State Street Corp Boston, MA5.8MShares$123 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.13MShares$66.6 Million1.62% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.01MShares$64 Million0.02% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.18B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...